| Literature DB >> 34808094 |
Omar Harfouch, Paul M Luethy, Mandee Noval, Jonathan D Baghdadi.
Abstract
We report a case of septic shock attributable to monomicrobial bloodstream infection secondary to Wohlfahrtiimonas chitiniclastica infection. This case suggests that W. chitiniclastica likely possesses the virulence to cause severe disease. Culture-independent techniques were essential in the identification of this organism, which enabled selection of appropriate therapy.Entities:
Keywords: Maryland; United States; Wohlfahrtiimonas chitiniclastica; bacteremia; bacteria; bacterial infection; bloodstream infections; infection; sepsis; skin; soft tissue
Mesh:
Year: 2021 PMID: 34808094 PMCID: PMC8632184 DOI: 10.3201/eid2712.210327
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Published cases of Wohlfahrtiimonas chitiniclastica bloodstream infection*
| Country of origin (reference) | Age, y/sex; housing status; presentation | Bacteria identified on blood cultures | Microbiology tools used | Antimicrobial agents and duration of treatment | Outcome |
|---|---|---|---|---|---|
| France ( | 60/F; homeless; fatigue and ulcers to the scalp |
| 16S rRNA sequencing | Ceftriaxone; duration not defined | Survival |
| Argentina ( | 70/M; homeless; altered mental status, septic shock, and plaques in the inguinal region |
| 16S rRNA sequencing | Ciprofloxacin and ampicillin/sulbactam; duration not defined | Death |
| Washington, USA ( | 57/M; stable home; wet gangrene of the ankle, septic shock, and multi-organ failure | Propionibacterium acnes, | MALDI-TOF mass spectrometry and 16S rRNA sequencing | No mention of antimicrobials used | Death |
| Ohio, USA ( | 41/F; stable home; abdominal pain and sacral osteomyelitis | MALDI-TOF mass spectrometry | Vancomycin, cefepime, and metronidazole; duration of 6 wks | Death from | |
| Indiana, USA ( | 37/M; not specified; necrotizing infection of lower extremities | Not specified | Piperacillin/tazobactam, clindamycin and vancomycin, then cefepime; duration of 10 d | Survival | |
| United Kingdom ( | 82/F; stable home; unconscious | MALDI-TOF mass spectrometry and 16S rRNA sequencing | Cefuroxime, metronidazole, and clarithromycin, then flucloxacillin; duration of 7 d | Survival | |
| Australia ( | 54/M; stable home; unconscious, septic shock and myasis of the foot and toes | MALDI-TOF mass spectrometry | Piperacillin/tazobactam, then meropenem, then ciprofloxacin; duration of 3 wks | Survival | |
| Hawaii, USA ( | 72/M; stable home; unconscious, septic shock, and myasis of the umbilical cord | 16S rRNA sequencing | Piperacillin/tazobactam, clindamycin, and vancomycin; duration not specified | Death | |
| Japan ( | 75/M; homeless; unconscious | MALDI-TOF mass spectrometry and 16S rRNA sequencing | Cefazolin, then vancomycin, cefepime, and metronidazole; duration not specified | Survival | |
| North Dakota, USA (Appendix reference | 70/M; stable home; fall |
| Not specified | Levofloxacin; duration not specified | Survival |
| Pennsylvania, USA (Appendix reference | 82/M; stable home; fall and confusion, myasis of the lower extremities and toes | MALDI-TOF mass spectrometry | Daptomycin for 6 wks Ceftriaxone for 2 wks | Survival |
*Appendix. MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight.